Sandoglobulin: transfer patients to liquid formulation as soon as possible

Patients currently being treated with Sandoglobulin (human normal immunoglobulin) powder for solution for infusion should be transferred to Sandoglobulin NF Liquid (solution for infusion) as soon as is practically possible.

Sandoglobulin NF Liquid is available as a 12% solution in 6g/50ml and 12g/100ml presentations at a cost of £186.36 and £372.72, respectively.

In addition to being more convenient than the powdered formulation, the liquid offers improved safety by virtue of its three-stage pathogen inactivation process during manufacture, low IgA levels and being free from carbohydrate stabilisers.

Sandoglobulin powder for solution for infusion 1g, 6g and 12g has been discontinued.

Further information: ZLB Behring Ltd, Hayworth House, Market Place, Haywards Heath, West Sussex RH16 1DB. Tel: (01444) 447400.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Live updates: Coronavirus (COVID-19) in the UK

Live updates: Coronavirus (COVID-19) in the UK

Use our timeline to follow the latest coronavirus developments...

Inhaler prescribing guidance issued as spike in demand causes shortages

Inhaler prescribing guidance issued as spike in demand causes shortages

Prescribers have been urged not to extend repeat prescription...

Free coronavirus news and resources on MIMS, MIMS Learning and GPonline

Free coronavirus news and resources on MIMS, MIMS Learning and GPonline

As the coronavirus crisis continues, we at Haymarket...

Transdermal estradiol spray offers new treatment option for HRT

Transdermal estradiol spray offers new treatment option for HRT

Lenzetto (estradiol) is the first transdermal spray...